TY - JOUR AU - Fulda, S. PY - 2009 DA - 2009// TI - Tumor resistance to apoptosis JO - Int J Cancer VL - 124 ID - Fulda2009 ER - TY - JOUR AU - Shah, K. AU - Rawal, R. M. PY - 2019 DA - 2019// TI - Genetic and epigenetic modulation of drug resistance in cancer: challenges and opportunities JO - Curr Drug Metab VL - 20 ID - Shah2019 ER - TY - JOUR AU - Lane, A. A. AU - Chabner, B. A. PY - 2009 DA - 2009// TI - Histone deacetylase inhibitors in cancer therapy JO - J Clin Oncol VL - 27 ID - Lane2009 ER - TY - JOUR AU - Schrump, D. S. PY - 2009 DA - 2009// TI - Cytotoxicity mediated by histone deacetylase inhibitors in cancer cells: mechanisms and potential clinical implications JO - Clin Cancer Res VL - 15 ID - Schrump2009 ER - TY - JOUR AU - Xu, W. S. AU - Parmigiani, R. B. AU - Marks, P. A. PY - 2007 DA - 2007// TI - Histone deacetylase inhibitors: molecular mechanisms of action JO - Oncogene VL - 26 ID - Xu2007 ER - TY - JOUR AU - Losson, H. AU - Schnekenburger, M. AU - Dicato, M. AU - Diederich, M. PY - 2020 DA - 2020// TI - HDAC6-an emerging target against chronic myeloid leukemia? JO - Cancers VL - 12 ID - Losson2020 ER - TY - JOUR AU - Pulukuri, S. M. AU - Gorantla, B. AU - Rao, J. S. PY - 2007 DA - 2007// TI - Inhibition of histone deacetylase activity promotes invasion of human cancer cells through activation of urokinase plasminogen activator JO - J Biol Chem VL - 282 ID - Pulukuri2007 ER - TY - JOUR AU - Kim, S. N. AU - Kim, N. H. AU - Lee, W. AU - Seo, D. W. AU - Kim, Y. K. PY - 2009 DA - 2009// TI - Histone deacetylase inhibitor induction of P-glycoprotein transcription requires both histone deacetylase 1 dissociation and recruitment of CAAT/enhancer binding protein beta and pCAF to the promoter region JO - Mol Cancer Res VL - 7 ID - Kim2009 ER - TY - JOUR AU - Fantin, V. R. AU - Richon, V. M. PY - 2007 DA - 2007// TI - Mechanisms of resistance to histone deacetylase inhibitors and their therapeutic implications JO - Clin Cancer Res VL - 13 ID - Fantin2007 ER - TY - JOUR AU - Robey, R. W. AU - Chakraborty, A. R. AU - Basseville, A. AU - Luchenko, V. AU - Bahr, J. AU - Zhan, Z. PY - 2011 DA - 2011// TI - Histone deacetylase inhibitors: emerging mechanisms of resistance JO - Mol Pharm VL - 8 ID - Robey2011 ER - TY - JOUR AU - Bayat, S. AU - Shekari Khaniani, M. AU - Choupani, J. AU - Alivand, M. R. AU - Mansoori, D. e. r. a. k. h. s. h. a. n. S. PY - 2018 DA - 2018// TI - HDACis (class I), cancer stem cell, and phytochemicals: cancer therapy and prevention implications JO - Biomed Pharmacother VL - 97 ID - Bayat2018 ER - TY - JOUR AU - Suraweera, A. AU - O’Byrne, K. J. AU - Richard, D. J. PY - 2018 DA - 2018// TI - Combination therapy with histone deacetylase inhibitors (HDACi) for the treatment of cancer: achieving the full therapeutic potential of HDACi JO - Front Oncol VL - 8 ID - Suraweera2018 ER - TY - JOUR AU - Kang, D. W. AU - Choi, K. Y. AU - Min do, S. PY - 2014 DA - 2014// TI - Functional regulation of phospholipase D expression in cancer and inflammation JO - J Biol Chem VL - 289 ID - Kang2014 ER - TY - JOUR AU - Kim, J. AU - Lee, Y. H. AU - Kwon, T. K. AU - Chang, J. S. AU - Chung, K. C. AU - Min, D. S. PY - 2006 DA - 2006// TI - Phospholipase D prevents etoposide-induced apoptosis by inhibiting the expression of early growth response-1 and phosphatase and tensin homologue deleted on chromosome 10 JO - Cancer Res VL - 66 ID - Kim2006 ER - TY - JOUR AU - Frohman, M. A. PY - 2015 DA - 2015// TI - The phospholipase D superfamily as therapeutic targets JO - Trends Pharmacol Sci VL - 36 ID - Frohman2015 ER - TY - JOUR AU - Uchida, N. AU - Okamura, S. AU - Nagamachi, Y. AU - Yamashita, S. PY - 1997 DA - 1997// TI - Increased phospholipase D activity in human breast cancer JO - J Cancer Res Clin Oncol VL - 123 ID - Uchida1997 ER - TY - JOUR AU - Saito, M. AU - Iwadate, M. AU - Higashimoto, M. AU - Ono, K. AU - Takebayashi, Y. AU - Takenoshita, S. PY - 2007 DA - 2007// TI - Expression of phospholipase D2 in human colorectal carcinoma JO - Oncol Rep VL - 18 ID - Saito2007 ER - TY - JOUR AU - Uchida, N. AU - Okamura, S. AU - Kuwano, H. PY - 1999 DA - 1999// TI - Phospholipase D activity in human gastric carcinoma JO - Anticancer Res VL - 19 ID - Uchida1999 ER - TY - JOUR AU - Chittur, S. V. AU - Sangster-Guity, N. AU - McCormick, P. J. PY - 2008 DA - 2008// TI - Histone deacetylase inhibitors: a new mode for inhibition of cholesterol metabolism JO - BMC Genomics VL - 9 ID - Chittur2008 ER - TY - JOUR AU - Yamada, Y. AU - Banno, Y. AU - Yoshida, H. AU - Kikuchi, R. AU - Akao, Y. AU - Murate, T. PY - 2006 DA - 2006// TI - Catalytic inactivation of human phospholipase D2 by a naturally occurring Gly901Asp mutation JO - Arch Med Res VL - 37 ID - Yamada2006 ER - TY - JOUR AU - Wood, L. D. AU - Parsons, D. W. AU - Jones, S. AU - Lin, J. AU - Sjoblom, T. AU - Leary, R. J. PY - 2007 DA - 2007// TI - The genomic landscapes of human breast and colorectal cancers JO - Science VL - 318 ID - Wood2007 ER - TY - JOUR AU - Henkels, K. M. AU - Farkaly, T. AU - Mahankali, M. AU - Segall, J. E. AU - Gomez-Cambronero, J. PY - 2011 DA - 2011// TI - Cell invasion of highly metastatic MTLn3 cancer cells is dependent on phospholipase D2 (PLD2) and Janus kinase 3 (JAK3) JO - J Mol Biol VL - 408 ID - Henkels2011 ER - TY - JOUR AU - Khan, O. AU - Thangue, N. B. PY - 2008 DA - 2008// TI - Drug Insight: histone deacetylase inhibitor-based therapies for cutaneous T-cell lymphomas JO - Nat Clin Pract Oncol VL - 5 ID - Khan2008 ER - TY - JOUR AU - Standaert, M. L. AU - Bandyopadhyay, G. AU - Perez, L. AU - Price, D. AU - Galloway, L. AU - Poklepovic, A. PY - 1999 DA - 1999// TI - Insulin activates protein kinases C-zeta and C-lambda by an autophosphorylation-dependent mechanism and stimulates their translocation to GLUT4 vesicles and other membrane fractions in rat adipocytes JO - J Biol Chem VL - 274 ID - Standaert1999 ER - TY - JOUR AU - Scott, S. A. AU - Selvy, P. E. AU - Buck, J. R. AU - Cho, H. P. AU - Criswell, T. L. AU - Thomas, A. L. PY - 2009 DA - 2009// TI - Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness JO - Nat Chem Biol VL - 5 ID - Scott2009 ER - TY - JOUR AU - Kang, H. R. AU - Choi, H. G. AU - Jeon, C. K. AU - Lim, S. J. AU - Kim, S. H. PY - 2016 DA - 2016// TI - Butyrate-mediated acquisition of chemoresistance by human colon cancer cells JO - Oncol Rep VL - 36 ID - Kang2016 ER - TY - JOUR AU - Kim, D. R. AU - Park, M. Y. AU - Lee, C. S. AU - Shim, S. H. AU - Yoon, H. I. AU - Lee, J. H. PY - 2011 DA - 2011// TI - Combination of vorinostat and adenovirus-TRAIL exhibits a synergistic antitumor effect by increasing transduction and transcription of TRAIL in lung cancer cells JO - Cancer Gene Ther VL - 18 ID - Kim2011 ER - TY - JOUR AU - Koyama, M. AU - Izutani, Y. AU - Goda, A. E. AU - Matsui, T. A. AU - Horinaka, M. AU - Tomosugi, M. PY - 2010 DA - 2010// TI - Histone deacetylase inhibitors and 15-deoxy-Delta 12,14-prostaglandin J2 synergistically induce apoptosis JO - Clin Cancer Res VL - 16 ID - Koyama2010 ER - TY - JOUR AU - Wei, Y. AU - Kadia, T. AU - Tong, W. AU - Zhang, M. AU - Jia, Y. AU - Yang, H. PY - 2010 DA - 2010// TI - The combination of a histone deacetylase inhibitor with the Bcl-2 homology domain-3 mimetic GX15-070 has synergistic antileukemia activity by activating both apoptosis and autophagy JO - Clin Cancer Res VL - 16 ID - Wei2010 ER - TY - JOUR AU - Zhang, B. AU - Strauss, A. C. AU - Chu, S. AU - Li, M. AU - Ho, Y. AU - Shiang, K. D. PY - 2010 DA - 2010// TI - Effective targeting of quiescent chronic myelogenous leukemia stem cells by histone deacetylase inhibitors in combination with imatinib mesylate JO - Cancer Cell VL - 17 ID - Zhang2010 ER - TY - JOUR AU - Kandori, S. AU - Kojima, T. AU - Matsuoka, T. AU - Yoshino, T. AU - Sugiyama, A. AU - Nakamura, E. PY - 2018 DA - 2018// TI - Phospholipase D2 promotes disease progression of renal cell carcinoma through the induction of angiogenin JO - Cancer Sci VL - 109 ID - Kandori2018 ER - TY - JOUR AU - Liu, M. AU - Fu, Z. AU - Wu, X. AU - Du, K. AU - Zhang, S. AU - Zeng, L. PY - 2016 DA - 2016// TI - Inhibition of phospholipaseD2 increases hypoxia-induced human colon cancer cell apoptosis through inactivating of the PI3K/AKT signaling pathway JO - Tumour Biol VL - 37 ID - Liu2016 ER - TY - JOUR AU - Hwang, W. C. AU - Kim, M. K. AU - Song, J. H. AU - Choi, K. Y. AU - Min, D. S. PY - 2014 DA - 2014// TI - Inhibition of phospholipase D2 induces autophagy in colorectal cancer cells JO - Exp Mol Med VL - 46 ID - Hwang2014 ER - TY - JOUR AU - Noble, A. R. AU - Hogg, K. AU - Suman, R. AU - Berney, D. M. AU - Bourgoin, S. AU - Maitland, N. J. PY - 2019 DA - 2019// TI - Phospholipase D2 in prostate cancer: protein expression changes with Gleason score JO - Br J Cancer VL - 121 ID - Noble2019 ER - TY - JOUR AU - Gore, S. D. PY - 2005 DA - 2005// TI - Combination therapy with DNA methyltransferase inhibitors in hematologic malignancies JO - Nat Clin Pract Oncol VL - 2 ID - Gore2005 ER - TY - JOUR AU - Stazi, G. AU - Fioravanti, R. AU - Mai, A. AU - Mattevi, A. AU - Valente, S. PY - 2019 DA - 2019// TI - Histone deacetylases as an epigenetic pillar for the development of hybrid inhibitors in cancer JO - Curr Opin Chem Biol VL - 50 ID - Stazi2019 ER - TY - JOUR AU - Kang, D. W. AU - Park, M. H. AU - Lee, Y. J. AU - Kim, H. S. AU - Kwon, T. K. AU - Min, D. S. PY - 2008 DA - 2008// TI - Phorbol ester up-regulates phospholipase D1 but not phospholipase D2 expression through a PKC/Ras/ERK/NFkappaB-dependent pathway and enhances matrix metalloproteinase-9 secretion in colon cancer cells JO - J Biol Chem VL - 283 ID - Kang2008 ER - TY - JOUR AU - Colman, R. W. AU - Pixley, R. A. AU - Sainz, I. M. AU - Song, J. S. AU - Isordia-Salas, I. AU - Muhamed, S. N. PY - 2003 DA - 2003// TI - Inhibition of angiogenesis by antibody blocking the action of proangiogenic high-molecular-weight kininogen JO - J Thromb Haemost VL - 1 ID - Colman2003 ER -